Specifically, different studies using the TNBC cell lines MDA-MB231 or SUM159 have shown that ERK3 knockdown reduces metastatic burden due to decreased migration and invasion ability and reduced cancer cell survival (14–16). This evidence concerns the gene MAPK12 and cancer.